- ICH GCP
- Registro delle prove cliniche dell'UE
Ultime prove
EudraCT Number: 2004-002197-34 | Sponsor Protocol Number: 04/Q1104/27 | Start Date: 2004-12-14 | ||||||
Sponsor Name: University College London | ||||||||
Full Title: A phase III multicentre randomised clinical trial comparing rituximab with CHOP given every 14 days and rituximab with CHOP given every 21 days for the treatment of patients with newly diagnosed d... | ||||||||
Medical condition: Newly diagnosed diffuse large B cell non-Hodgkin's lymphoma | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-002701-68 | Sponsor Protocol Number: PSN9301CS01 | Start Date: 2004-12-13 | ||||||
Sponsor Name: Prosidion Ltd. | ||||||||
Full Title: A randomised, double-blind, placebo-controlled, multiple dose, time-lagged parallel groups trial, investigating the pharmacodynamics, the safety and tolerability and the pharmacokinetics of PSN9301... | ||||||||
Medical condition: Diabetes mellitus type 2 | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: DE (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-003764-30 | Sponsor Protocol Number: D/P2/04/3 | Start Date: 2004-12-13 | |||||||||||
Sponsor Name: Diamyd Therapeutics AB | |||||||||||||
Full Title: A Phase II, Randomised, Double-Blind, Placebo-controlled, Multi-centre Study to Investigate the Impact of Diamyd on the Progression of diabetes in Patients Newly Diagnosed with Type 1 Diabetes Mell... | |||||||||||||
Medical condition: Type 1 diabetes | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004083-77 | Sponsor Protocol Number: NO 002 CS 001 | Start Date: 2004-12-13 | ||||||
Sponsor Name: Disphar International B.V. | ||||||||
Full Title: A Randomised, International, Multicenter Study to assess the Efficacy and Safety of Mesalazine EC tablets 500 mg (4.5g/daily) and Salofalk® tablets 500 mg (4.5 g/daily) in the Treatment of Moderate... | ||||||||
Medical condition: Moderate active Crohn disease | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: CZ (Completed) SK (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000623-16 | Sponsor Protocol Number: 1100.1454 | Start Date: 2004-12-13 | ||||||
Sponsor Name: Boehringer Ingelheim Ltd | ||||||||
Full Title: A retrospective study to compare the 3-year antiviral efficacy of nevirapine and efavirenz in combination with D4T and 3TC in 2NN patients | ||||||||
Medical condition: Treatment of HIV-1 infection | ||||||||
|
||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) BE (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-002276-42 | Sponsor Protocol Number: 61/O4/OX/Rh | Start Date: 2004-12-13 | ||||||
Sponsor Name: IVAX Pharmaceuticals s.r.o. | ||||||||
Full Title: Tolerability and safety of Oxamet® in patients with acute rhinitis | ||||||||
Medical condition: Acute rhinitis. | ||||||||
|
||||||||
Population Age: Adults | Gender: Male, Female | |||||||
Trial protocol: CZ (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-003238-32 | Sponsor Protocol Number: v1 | Start Date: 2004-12-13 | ||||||
Sponsor Name: Dept. of Clinical Pharmacology | ||||||||
Full Title: Effect of pioglitazone on portal and systemic hemodynamics in patients with advanced cirrhosis | ||||||||
Medical condition: Cirrhosis of the liver | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: AT (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001989-41 | Sponsor Protocol Number: 26866138-MMY-3002 | Start Date: 2004-12-13 | ||||||
Sponsor Name: Janssen-Cilag Kft. | ||||||||
Full Title: An Open-Label, Randomized Study of VELCADE/Melphalan/Prednisone versus Melphalan/Prednisone in subjects with previously untreated Multiple Myeloma. | ||||||||
Medical condition: First-Line Multiple Myeloma | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: HU (Completed) FI (Completed) AT (Completed) CZ (Completed) IE (Completed) GB (Completed) DE (Completed) BE (Completed) ES (Ongoing) IT (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-002985-39 | Sponsor Protocol Number: ML18253 | Start Date: 2004-12-13 | |||||||||||
Sponsor Name: ROCHE | |||||||||||||
Full Title: A multicenter, randomized, controlled study comparing the efficacy and safety of 48 weeks of 40kD branched pegylated interferon alfa-2a (PEGASYS, Ro 25-8310) versus 96 weeks of PEGASYS, alone or in... | |||||||||||||
Medical condition: Treatment of chronic hepatitis B, HBeAg-negative | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001953-27 | Sponsor Protocol Number: 9321 | Start Date: 2004-12-13 | ||||||
Sponsor Name: University Hospitals of Leicester NHS Trust | ||||||||
Full Title: The Pharmacokinetics of Systemic Corticosteriods in Refractory Asthma | ||||||||
Medical condition: Severe, refractory asthma | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) | ||||||||
Trial results: View results |